Generic Name
VinpocetineTherapeutic Class: Drugs of Nervous System
Indications:
All forms of acute and chronic cerebral circulatory insufficiency: TIA (Transient Ischaemic Attack), reversible ischaemic neurological deficiency, progressive stroke, completed stroke, post-apoplectic conditions, multi-infarct dementia, cerebral arteriosclerosis, post-traumatic, hypertensive encephalopathy, etc. For the reduction of psychic or neurological symptoms of cerebral insufficiency (e.g., memory disturbance, dizziness, headache, aphasia, locomotor disorder, etc.).
Ophthalmology: It can be used for the treatment of vascular disorder of the choroid and retina due to arteriosclerosis, vasospasm, macular degeneration, arterial and venous thrombosis or embolism, and glaucoma secondary to the above-mentioned disorders.
Otology: For the treatment of impaired hearing of vascular or toxic(Iatrogenic) origin, presbyacusis, Menier's disease, cochleovestibular neuritis, tinnitus, and dizziness of labyrinth origin.
Presentation:
Each tablet contains Vinpocetine BP 5 mg.
Description:
All forms of acute and chronic cerebral circulatory insufficiency: TIA (Transient Ischaemic Attack), reversible ischaemic neurological deficiency, progressive stroke, completed stroke, post-apoplectic conditions, multi-infarct dementia, cerebral arteriosclerosis, post-traumatic, hypertensive encephalopathy, etc. For the reduction of psychic or neurological symptoms of cerebral insufficiency (e.g., memory disturbance, dizziness, headache, aphasia, locomotor disorder, etc.).
Ophthalmology: It can be used for the treatment of vascular disorder of the choroid and retina due to arteriosclerosis, vasospasm, macular degeneration, arterial and venous thrombosis or embolism, and glaucoma secondary to the above-mentioned disorders.
Otology: For the treatment of impaired hearing of vascular or toxic(Iatrogenic) origin, presbyacusis, Menier's disease, cochleovestibular neuritis, tinnitus, and dizziness of labyrinth origin.
Presentation:
Each tablet contains Vinpocetine BP 5 mg.
Description:
Vinpocetine improves cerebral metabolism. It increases the glucose and oxygen consumption and utilization of the brain tissue, improves the hypoxia tolerance of the brain cell, shifts glucose metabolism towards the energetically more favorable aerobic pathway, exerts antioxidant activity, as a result of all the effects it is a cerebroprotective compound. Vinsetine considerably improves cerebral microcirculation.
Dosage & Administration:
Vinpocetine is taken 1-2 tablets three times daily with meals. The maintenance dose is 1 tablet three times daily over long periods.
Side Effects:
Vinpocetine is well tolerated. In some cases, transient fall of blood pressure and tachycardia may occur.
Precautions:
Because Vinpocetine can reduce the ability of blood to clot, those individuals with a tendency to bleed should avoid Vinpocetine.
Drug Interaction:
Should not be given with Heparin.
Dosage & Administration:
Vinpocetine is taken 1-2 tablets three times daily with meals. The maintenance dose is 1 tablet three times daily over long periods.
Side Effects:
Vinpocetine is well tolerated. In some cases, transient fall of blood pressure and tachycardia may occur.
Precautions:
Because Vinpocetine can reduce the ability of blood to clot, those individuals with a tendency to bleed should avoid Vinpocetine.
Drug Interaction:
Should not be given with Heparin.
Storage:
Keep in a dry place far away from light and warmth. exclude the reach of Children's.